Unlock stock picks and a broker-level newsfeed that powers Wall Street.
4,205.00
+55.00
+(1.33%)
At close: April 4 at 3:30:30 PM GMT+9
Key Executives
Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in KRW.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Chul-Joong Kwon | CEO & Director | -- | -- | 1965 |
| Mr. Byung-Tak Yoo | CEO & Director | -- | -- | 1974 |
| Mr. Woo-Jae Lee | MD & Chief of Marketing Office | -- | -- | 1969 |
| Mr. Haeseok Lee | Executive Director | -- | -- | 1980 |
| Mr. Min-Cheol Kwak | Executive Director | -- | -- | 1975 |
SELVAS Healthcare, Inc.
155, Sinseong-ro
Yuseong-Gu Sinseong-dong
Daejeon, 34109
South Korea
- Sector:
- Healthcare
- Industry: Medical Devices
Description
SELVAS Healthcare, Inc. operates as a medical device company in South Korea. The company provides body composition analyzers and automatic blood pressure monitors for hospitals. It also offers Braille Sense notetakers and other products for blind and visually impaired people under the HIMS brand name, as well as provides digital health products under the ACCUNIQ brand name. The company was formerly known as Jawon Medical Co., Ltd. and changed its name to SELVAS Healthcare, Inc. in September 2016. SELVAS Healthcare, Inc. was founded in 1999 and is headquartered in Daejeon, South Korea.
Corporate Governance
SELVAS Healthcare, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
Upcoming Events Information Not Available
Recent Events
Recent Events Information Not Available